Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

NCT00148850 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

130

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-Associated Lipodystrophy Syndrome
HIV Infections

Interventions

DRUG: Pioglitazone

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]